Skip to main content

More Filters

1,082 results

Showing: 961 - 980 of 1082 results
  1. pAAV-EF1a-iFlpV (AAV1)

    Viral prep
    #140137-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-iFlpV (#140137). In addition to the viral particles, you will also receive purified pAAV-EF1a-iFlpV plasmid DNA. EF1a-driven, light-inducible iFlpV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only
  2. Human CRISPR Metabolic Gene Knockout Library (Lentiviral Prep)

    Viral prep
    #110066-LV
    Purpose
    Ready-to-use Lentiviral Prep particles produced from Human CRISPR Metabolic Gene Knockout Library (#110066). In addition to the viral particles, you will also receive purified Human CRISPR Metabolic Gene Knockout Library plasmid DNA.
    Depositor
    Available since
    Aug. 20, 2026
    Availability
    Academic Institutions and Nonprofits only
  3. AAV_pMBP-EGFP-caax (AAV8)

    Viral prep
    #190155-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AAV_pMBP-EGFP-caax (#190155). In addition to the viral particles, you will also receive purified AAV_pMBP-EGFP-caax plasmid DNA. MBP-driven EGFP expression in oligodendrocytes. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    MBP
    Available since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-Ef1a-DIO_EGFP-GFE3 (AAV1)

    Viral prep
    #79871-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO_EGFP-GFE3 (#79871). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO_EGFP-GFE3 plasmid DNA. EF1a-driven, Cre-dependent expression of GFP-GFE3. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
  5. AiP14871: pAAV-AiE0779m_3xC2-minBG-RiboL1-jGCaMP8s-WPRE3-BGHpA (Alias: CN4871) (AAV1)

    Viral prep
    #214865-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AiP14871: pAAV-AiE0779m_3xC2-minBG-RiboL1-jGCaMP8s-WPRE3-BGHpA (Alias: CN4871) (#214865). In addition to the viral particles, you will also receive purified AiP14871: pAAV-AiE0779m_3xC2-minBG-RiboL1-jGCaMP8s-WPRE3-BGHpA (Alias: CN4871) plasmid DNA. Neuronal expression of soma-targeted (RL-10, ribosomal tag) jGCaMP8s under the minBG promoter. These AAV preparations are suitable purity for injection into animals.
    Available since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
  6. AAV-∆Hapln1 (AAV8)

    Viral prep
    #200778-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AAV-∆Hapln1 (#200778). In addition to the viral particles, you will also receive purified AAV-∆Hapln1 plasmid DNA. Syn-driven, HAPLN1(delta40-154)-cfGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
  7. AAV-HAPLN1 (AAV8)

    Viral prep
    #200777-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AAV-HAPLN1 (#200777). In addition to the viral particles, you will also receive purified AAV-HAPLN1 plasmid DNA. Syn-driven, HAPLN1-cfGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
  8. AAV-cfGFP (AAV8)

    Viral prep
    #200773-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AAV-cfGFP (#200773). In addition to the viral particles, you will also receive purified AAV-cfGFP plasmid DNA. Syn-driven, cysteine-free GFP (cfGFP) expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV_BiPVe4_GCaMP6f (AAV1)

    Viral prep
    #213939-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV_BiPVe4_ChR2_mCherry (AAV1)

    Viral prep
    #213937-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe4_ChR2_mCherry (#213937). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    mCherry
    Available since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV_BiSSTe4_GCaMP6f (AAV1)

    Viral prep
    #213947-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  12. pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (AAV8)

    Viral prep
    #61592-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (#61592). In addition to the viral particles, you will also receive purified pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA plasmid DNA. CMV-driven expression of SaCas9. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only
  13. AiP13987: pAAV-AiE0452h_3xC2-minBG-jRGECO1a-WPRE3-BGHpA (Alias: CN3987) (AAV PHP.eB)

    Viral prep
    #214851-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from AiP13987: pAAV-AiE0452h_3xC2-minBG-jRGECO1a-WPRE3-BGHpA (Alias: CN3987) (#214851). In addition to the viral particles, you will also receive purified AiP13987: pAAV-AiE0452h_3xC2-minBG-jRGECO1a-WPRE3-BGHpA (Alias: CN3987) plasmid DNA. minBG-driven expression of jRGECO1a in striatal indirect pathway medium spiny neurons (D2 MSNs). These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Available since
    Jan. 27, 2025
    Availability
    Academic Institutions and Nonprofits only
  14. AiP12787 - pAAV-AiE0140h_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN2787) (AAV PHP.eB)

    Viral prep
    #191726-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from AiP12787 - pAAV-AiE0140h_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN2787) (#191726). In addition to the viral particles, you will also receive purified AiP12787 - pAAV-AiE0140h_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN2787) plasmid DNA. Expression of SYFP2 in striatal Pvalb+ neurons. Note strong cortical Pvalb and L5 ET neuron expression. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Available since
    Nov. 13, 2024
    Availability
    Academic Institutions and Nonprofits only
  15. pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE (AAV5)

    Viral prep
    #218879-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE (#218879). In addition to the viral particles, you will also receive purified pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE plasmid DNA. Syn-driven, Cre-dependent expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  16. pGP-AAV-GFAP-iGABASnFR2-WPRE (AAV1)

    Viral prep
    #218871-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-GFAP-iGABASnFR2-WPRE (#218871). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor iGABASnFR2 (positive change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Available since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV-hSyn-GRAB_OTmut (AAV9)

    Viral prep
    #185388-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSyn-GRAB_OTmut (#185388). In addition to the viral particles, you will also receive purified pAAV-hSyn-GRAB_OTmut plasmid DNA. hSyn-driven expression of the genetically-encoded fluorescent oxytocin(OT) control sensor GRAB_OTmut in neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available since
    June 26, 2024
    Availability
    Academic Institutions and Nonprofits only
  18. AAV-hSyn-Soma-jGCaMP8f (AAV Retrograde)

    Viral prep
    #169258-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from AAV-hSyn-Soma-jGCaMP8f (#169258). In addition to the viral particles, you will also receive purified AAV-hSyn-Soma-jGCaMP8f plasmid DNA. Synapsin-driven neuronal expression of soma-targeted calcium sensor jGCaMP8f. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available since
    March 18, 2024
    Availability
    Academic Institutions and Nonprofits only
  19. pAAV-Ef1a-mCherry (AAV PHP.eB)

    Viral prep
    #114470-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-Ef1a-mCherry (#114470). In addition to the viral particles, you will also receive purified pAAV-Ef1a-mCherry plasmid DNA. EF1a-driven mCherry expression. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    mCherry
    Available since
    Feb. 16, 2024
    Availability
    Academic Institutions and Nonprofits only
  20. pAAV-CAG-eYFP (AAV5)

    Viral prep
    #104055-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EYFP
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only
Showing: 961 - 980 of 1082 results